financetom
Business
financetom
/
Business
/
Russia's Sberbank: AI to make 60% of corporate loan decisions by year-end
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Russia's Sberbank: AI to make 60% of corporate loan decisions by year-end
Mar 5, 2024 6:39 AM

MOSCOW (Reuters) - Decisions on 60% of corporate loans issued by Russia's top lender Sberbank will be made using artificial intelligence (AI) by the end of this year, CEO German Gref said on Tuesday.

Gref has placed artificial intelligence and digital transformation at the heart of the bank's strategy, as Russia adjusts to life without Western technology after sanctions over the conflict in Ukraine.

Sberbank is investing more than 450 billion roubles ($5 billion) in IT in 2024-2026 and expects profit generated from AI in that period to amount to about 800 billion roubles.

Sberbank's lending decisions on consumer credit, mortgages and car loans are all being made by AI, and Gref said the figure for corporate lending was 40%.

"The figure should amount to 60% by the end of the year and by end-2026 the figure should reach 80%," Gref said at a festival in Sochi.

Sberbank has more than 3 million corporate clients.

Sberbank wants to be seen as a technology company with a banking licence and is also working on producing hardware like microchips and servers. Gref said reliance on vendors had waned.

"We have created our own operating system," he said. "All the computer equipment that is used within the bank is gradually being replaced by ours."

President Vladimir Putin has hailed Sberbank for developing its own generative AI and language models and warned that the West should not be allowed to develop a monopoly in the AI sphere.

China and the United States are leading the development of AI, which many researchers and global leaders think will transform the world and revolutionise society in a way similar to the introduction of computers in the 20th century.

($1 = 91.0205 roubles)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Boeing Reportedly Close to Buying Back Spirit AeroSystems
Update: Market Chatter: Boeing Reportedly Close to Buying Back Spirit AeroSystems
Jun 21, 2024
08:47 AM EDT, 06/21/2024 (MT Newswires) -- (Adds deal details in fourth and sixth paragraph) Boeing ( BA ) is close to buying back its former subsidiary Spirit AeroSystems ( SPR ) following the struggling supplier's notable progress in separate talks with European rival Airbus, Reuters reported Thursday, citing people familiar with the matter. The company started discussions earlier this...
Sector Update: Consumer
Sector Update: Consumer
Jun 21, 2024
08:47 AM EDT, 06/21/2024 (MT Newswires) -- Consumer stocks were edging higher pre-bell Friday with the Consumer Staples Select Sector SPDR Fund (XLP) marginally advancing and the Consumer Discretionary Select Sector SPDR Fund (XLY) up 0.2% recently. PVH (PVH) shares were up over 2% after the company's Tommy Hilfiger brand said it has entered a multi-year partnership with the US...
Pan American Energy Completes Spring 2024 Field Prospecting and Sampling Program at Big Mack Lithium Project in Ontario
Pan American Energy Completes Spring 2024 Field Prospecting and Sampling Program at Big Mack Lithium Project in Ontario
Jun 21, 2024
08:48 AM EDT, 06/21/2024 (MT Newswires) -- Pan American Energy ( PAANF ) said on Friday that it completed the Spring 2024 field prospecting and sampling program at the Big Mack Lithium Project located 80 kilometers north of Kenora, Ontario. The exploration program is part of a collaborative research project between Pan American Energy ( PAANF ) and the Institute...
Lexicon Pharmaceuticals Resubmits New Drug Application for Potential Type 1 Diabetes Therapy
Lexicon Pharmaceuticals Resubmits New Drug Application for Potential Type 1 Diabetes Therapy
Jun 21, 2024
08:47 AM EDT, 06/21/2024 (MT Newswires) -- Lexicon Pharmaceuticals ( LXRX ) said Friday that it has resubmitted its New Drug Application for sotagliflozin to supplement insulin therapy for persons with type 1 diabetes and chronic kidney disease, following multiple consultations with the US Food and Drug Administration. The application remains in filed status at the FDA and the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved